Chinese Patent Medicine Shufeng Jiedu Capsule for Acute Upper Respiratory Tract Infections: A Protocol of a Systematic Review of Randomized Clinical Trials

Review question / Objective: A systematic review and metaanalysis will be conducted to evaluate whether Chinese patent medicine Shufeng Jiedu capsule (SFJD) is effective in relieving symptoms, shortening the course, and influencing the use of antibiotics or antivirals in acute upper respiratory tract infections (AURTIs).Parallel group, randomized controlled trials in regardless of blinding will be included.SFJD capsule is used alone or in combination with symptomatic treatment or/and etiological treatment for AURTIs, including common cold, acute pharyngitis, acute laryngitis, herpangina, pharyngoconjunctival fever, acute rhinitis, or acute tonsillitis.INPLASY registration number: This protocol was registered with the International Platform of Registered Systematic Review and Meta-Analysis Protocols (INPLASY) on 22 May 2020 and was last u p d a t e d o n 2 2 M a y 2 0 2 0 ( r e g i s t r a t i o n n u m b e r INPLASY202050083).